Almost 20,000 patients are to be given subsidized medicinal cannabis in the UK as a part of first major trial to see the effects of the drug. Though medicinal cannabis is legal in Britain since last November, patients are finding difficulty to access it.
Medicines derived from the drug are not available on the health services hence the Project 21 will be launched in the UK to see the drug impact on 20,000 patients. The patients will be tested on seven health conditions including chronic pain, multiple sclerosis, epilepsy, post-traumatic stress disorder, Tourette’s anxiety, and drug addiction.
Data from the research will be collected every three months on the drug’s efficacy, safety, and patient-reported feedback. David Nutt, the professor in the Charity Drug Science, said that the trail will provide a clinical database for other medical prescribers to build on.
Cannabis is proving to be the most important innovation in medicine. Cannabis drugs are life-saving in many disorders like severe childhood epilepsy.
There are many children who died in the country in the last couple of years due to the unavailability of cannabis. This research will encourage the use of cannabis products and production in the country.
CBD products are getting legal status in more number of states and countries across the world. Hemp in the UK is legal since last November and the country has a large market for CBD products. These products are effective in many physical and mental ailments. They are helpful to cure depression, anxiety, insomnia, and other sicknesses as well.